nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CHRM3—ureter—urinary bladder cancer	0.106	0.359	CbGeAlD
Dicyclomine—CHRM3—muscle of abdomen—urinary bladder cancer	0.0763	0.258	CbGeAlD
Dicyclomine—CHRM2—prostate gland—urinary bladder cancer	0.0152	0.0514	CbGeAlD
Dicyclomine—CHRM1—prostate gland—urinary bladder cancer	0.0138	0.0468	CbGeAlD
Dicyclomine—CHRM3—prostate gland—urinary bladder cancer	0.0124	0.0419	CbGeAlD
Dicyclomine—CHRM3—smooth muscle tissue—urinary bladder cancer	0.00875	0.0296	CbGeAlD
Dicyclomine—CHRM3—renal system—urinary bladder cancer	0.00843	0.0285	CbGeAlD
Dicyclomine—CHRM3—urethra—urinary bladder cancer	0.00828	0.028	CbGeAlD
Dicyclomine—CHRM1—female reproductive system—urinary bladder cancer	0.00754	0.0255	CbGeAlD
Dicyclomine—CYP1A1—epithelium—urinary bladder cancer	0.0068	0.023	CbGeAlD
Dicyclomine—CHRM3—female reproductive system—urinary bladder cancer	0.00675	0.0229	CbGeAlD
Dicyclomine—CYP1A1—renal system—urinary bladder cancer	0.00631	0.0214	CbGeAlD
Dicyclomine—CYP1A1—urethra—urinary bladder cancer	0.0062	0.021	CbGeAlD
Dicyclomine—CYP1A1—female reproductive system—urinary bladder cancer	0.00505	0.0171	CbGeAlD
Dicyclomine—CYP1A1—vagina—urinary bladder cancer	0.00457	0.0155	CbGeAlD
Dicyclomine—CYP1A1—lymph node—urinary bladder cancer	0.00296	0.01	CbGeAlD
Dicyclomine—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00132	0.00187	CcSEcCtD
Dicyclomine—Discomfort—Cisplatin—urinary bladder cancer	0.00132	0.00187	CcSEcCtD
Dicyclomine—Tachycardia—Fluorouracil—urinary bladder cancer	0.00131	0.00186	CcSEcCtD
Dicyclomine—Affect lability—Epirubicin—urinary bladder cancer	0.00131	0.00186	CcSEcCtD
Dicyclomine—Anorexia—Gemcitabine—urinary bladder cancer	0.00131	0.00185	CcSEcCtD
Dicyclomine—Urticaria—Thiotepa—urinary bladder cancer	0.00129	0.00184	CcSEcCtD
Dicyclomine—Malaise—Etoposide—urinary bladder cancer	0.00129	0.00183	CcSEcCtD
Dicyclomine—Breast disorder—Methotrexate—urinary bladder cancer	0.00129	0.00183	CcSEcCtD
Dicyclomine—Face oedema—Epirubicin—urinary bladder cancer	0.00129	0.00183	CcSEcCtD
Dicyclomine—Abdominal pain—Thiotepa—urinary bladder cancer	0.00129	0.00183	CcSEcCtD
Dicyclomine—Anorexia—Fluorouracil—urinary bladder cancer	0.00128	0.00182	CcSEcCtD
Dicyclomine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00128	0.00181	CcSEcCtD
Dicyclomine—Oedema—Cisplatin—urinary bladder cancer	0.00128	0.00181	CcSEcCtD
Dicyclomine—Mood swings—Epirubicin—urinary bladder cancer	0.00126	0.00179	CcSEcCtD
Dicyclomine—Loss of consciousness—Etoposide—urinary bladder cancer	0.00126	0.00179	CcSEcCtD
Dicyclomine—Lethargy—Doxorubicin—urinary bladder cancer	0.00126	0.00179	CcSEcCtD
Dicyclomine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00125	0.00178	CcSEcCtD
Dicyclomine—Tachycardia—Cisplatin—urinary bladder cancer	0.00125	0.00177	CcSEcCtD
Dicyclomine—Insomnia—Gemcitabine—urinary bladder cancer	0.00124	0.00176	CcSEcCtD
Dicyclomine—Hypertension—Etoposide—urinary bladder cancer	0.00124	0.00176	CcSEcCtD
Dicyclomine—Diplopia—Doxorubicin—urinary bladder cancer	0.00123	0.00175	CcSEcCtD
Dicyclomine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00123	0.00175	CcSEcCtD
Dicyclomine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00122	0.00173	CcSEcCtD
Dicyclomine—Insomnia—Fluorouracil—urinary bladder cancer	0.00122	0.00173	CcSEcCtD
Dicyclomine—Somnolence—Gemcitabine—urinary bladder cancer	0.00122	0.00173	CcSEcCtD
Dicyclomine—Anorexia—Cisplatin—urinary bladder cancer	0.00122	0.00173	CcSEcCtD
Dicyclomine—Affect lability—Doxorubicin—urinary bladder cancer	0.00121	0.00172	CcSEcCtD
Dicyclomine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00121	0.00172	CcSEcCtD
Dicyclomine—Discomfort—Etoposide—urinary bladder cancer	0.00121	0.00171	CcSEcCtD
Dicyclomine—Breast disorder—Epirubicin—urinary bladder cancer	0.00121	0.00171	CcSEcCtD
Dicyclomine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.0012	0.0017	CcSEcCtD
Dicyclomine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.0012	0.0017	CcSEcCtD
Dicyclomine—Somnolence—Fluorouracil—urinary bladder cancer	0.0012	0.0017	CcSEcCtD
Dicyclomine—Face oedema—Doxorubicin—urinary bladder cancer	0.00119	0.00169	CcSEcCtD
Dicyclomine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00119	0.00169	CcSEcCtD
Dicyclomine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00119	0.00168	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00118	0.00168	CcSEcCtD
Dicyclomine—Fatigue—Gemcitabine—urinary bladder cancer	0.00118	0.00168	CcSEcCtD
Dicyclomine—Confusional state—Etoposide—urinary bladder cancer	0.00118	0.00167	CcSEcCtD
Dicyclomine—Muscular weakness—Epirubicin—urinary bladder cancer	0.00118	0.00167	CcSEcCtD
Dicyclomine—Constipation—Gemcitabine—urinary bladder cancer	0.00117	0.00166	CcSEcCtD
Dicyclomine—Pain—Gemcitabine—urinary bladder cancer	0.00117	0.00166	CcSEcCtD
Dicyclomine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00117	0.00166	CcSEcCtD
Dicyclomine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00117	0.00166	CcSEcCtD
Dicyclomine—Mood swings—Doxorubicin—urinary bladder cancer	0.00117	0.00166	CcSEcCtD
Dicyclomine—Asthenia—Thiotepa—urinary bladder cancer	0.00117	0.00166	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00116	0.00165	CcSEcCtD
Dicyclomine—Abdominal distension—Epirubicin—urinary bladder cancer	0.00116	0.00165	CcSEcCtD
Dicyclomine—Pruritus—Thiotepa—urinary bladder cancer	0.00115	0.00163	CcSEcCtD
Dicyclomine—Pain—Fluorouracil—urinary bladder cancer	0.00115	0.00163	CcSEcCtD
Dicyclomine—Paraesthesia—Cisplatin—urinary bladder cancer	0.00115	0.00163	CcSEcCtD
Dicyclomine—Tachycardia—Etoposide—urinary bladder cancer	0.00114	0.00162	CcSEcCtD
Dicyclomine—Dyspnoea—Cisplatin—urinary bladder cancer	0.00114	0.00161	CcSEcCtD
Dicyclomine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00113	0.00161	CcSEcCtD
Dicyclomine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00113	0.0016	CcSEcCtD
Dicyclomine—Breast disorder—Doxorubicin—urinary bladder cancer	0.00112	0.00158	CcSEcCtD
Dicyclomine—Anorexia—Etoposide—urinary bladder cancer	0.00111	0.00158	CcSEcCtD
Dicyclomine—Decreased appetite—Cisplatin—urinary bladder cancer	0.00111	0.00157	CcSEcCtD
Dicyclomine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00111	0.00157	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.0011	0.00156	CcSEcCtD
Dicyclomine—Drowsiness—Methotrexate—urinary bladder cancer	0.0011	0.00156	CcSEcCtD
Dicyclomine—Pain—Cisplatin—urinary bladder cancer	0.00109	0.00155	CcSEcCtD
Dicyclomine—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00109	0.00154	CcSEcCtD
Dicyclomine—Dizziness—Thiotepa—urinary bladder cancer	0.00108	0.00153	CcSEcCtD
Dicyclomine—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00107	0.00152	CcSEcCtD
Dicyclomine—Urticaria—Fluorouracil—urinary bladder cancer	0.00107	0.00152	CcSEcCtD
Dicyclomine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00105	0.00149	CcSEcCtD
Dicyclomine—Paraesthesia—Etoposide—urinary bladder cancer	0.00105	0.00149	CcSEcCtD
Dicyclomine—Dyspnoea—Etoposide—urinary bladder cancer	0.00104	0.00148	CcSEcCtD
Dicyclomine—Somnolence—Etoposide—urinary bladder cancer	0.00104	0.00148	CcSEcCtD
Dicyclomine—Vomiting—Thiotepa—urinary bladder cancer	0.00104	0.00147	CcSEcCtD
Dicyclomine—Drowsiness—Epirubicin—urinary bladder cancer	0.00103	0.00146	CcSEcCtD
Dicyclomine—Rash—Thiotepa—urinary bladder cancer	0.00103	0.00146	CcSEcCtD
Dicyclomine—Dermatitis—Thiotepa—urinary bladder cancer	0.00103	0.00146	CcSEcCtD
Dicyclomine—Headache—Thiotepa—urinary bladder cancer	0.00102	0.00145	CcSEcCtD
Dicyclomine—Decreased appetite—Etoposide—urinary bladder cancer	0.00102	0.00144	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00101	0.00143	CcSEcCtD
Dicyclomine—Fatigue—Etoposide—urinary bladder cancer	0.00101	0.00143	CcSEcCtD
Dicyclomine—Constipation—Etoposide—urinary bladder cancer	0.001	0.00142	CcSEcCtD
Dicyclomine—Pain—Etoposide—urinary bladder cancer	0.001	0.00142	CcSEcCtD
Dicyclomine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000992	0.00141	CcSEcCtD
Dicyclomine—Asthenia—Gemcitabine—urinary bladder cancer	0.000983	0.00139	CcSEcCtD
Dicyclomine—Pruritus—Gemcitabine—urinary bladder cancer	0.000969	0.00137	CcSEcCtD
Dicyclomine—Nausea—Thiotepa—urinary bladder cancer	0.000967	0.00137	CcSEcCtD
Dicyclomine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000964	0.00137	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000956	0.00136	CcSEcCtD
Dicyclomine—Pruritus—Fluorouracil—urinary bladder cancer	0.000953	0.00135	CcSEcCtD
Dicyclomine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000951	0.00135	CcSEcCtD
Dicyclomine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00094	0.00133	CcSEcCtD
Dicyclomine—Urticaria—Etoposide—urinary bladder cancer	0.000929	0.00132	CcSEcCtD
Dicyclomine—Abdominal pain—Etoposide—urinary bladder cancer	0.000924	0.00131	CcSEcCtD
Dicyclomine—Eye disorder—Methotrexate—urinary bladder cancer	0.000921	0.00131	CcSEcCtD
Dicyclomine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000918	0.0013	CcSEcCtD
Dicyclomine—Asthenia—Cisplatin—urinary bladder cancer	0.000916	0.0013	CcSEcCtD
Dicyclomine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000915	0.0013	CcSEcCtD
Dicyclomine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000891	0.00126	CcSEcCtD
Dicyclomine—Dizziness—Fluorouracil—urinary bladder cancer	0.00089	0.00126	CcSEcCtD
Dicyclomine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000889	0.00126	CcSEcCtD
Dicyclomine—Vomiting—Gemcitabine—urinary bladder cancer	0.000871	0.00124	CcSEcCtD
Dicyclomine—Mental disorder—Methotrexate—urinary bladder cancer	0.000864	0.00123	CcSEcCtD
Dicyclomine—Rash—Gemcitabine—urinary bladder cancer	0.000864	0.00123	CcSEcCtD
Dicyclomine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000863	0.00122	CcSEcCtD
Dicyclomine—Eye disorder—Epirubicin—urinary bladder cancer	0.000862	0.00122	CcSEcCtD
Dicyclomine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000862	0.00122	CcSEcCtD
Dicyclomine—Erythema—Methotrexate—urinary bladder cancer	0.000858	0.00122	CcSEcCtD
Dicyclomine—Headache—Gemcitabine—urinary bladder cancer	0.000858	0.00122	CcSEcCtD
Dicyclomine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000856	0.00122	CcSEcCtD
Dicyclomine—Vomiting—Fluorouracil—urinary bladder cancer	0.000856	0.00121	CcSEcCtD
Dicyclomine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000849	0.00121	CcSEcCtD
Dicyclomine—Rash—Fluorouracil—urinary bladder cancer	0.000849	0.0012	CcSEcCtD
Dicyclomine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000848	0.0012	CcSEcCtD
Dicyclomine—Headache—Fluorouracil—urinary bladder cancer	0.000844	0.0012	CcSEcCtD
Dicyclomine—Asthenia—Etoposide—urinary bladder cancer	0.000839	0.00119	CcSEcCtD
Dicyclomine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000833	0.00118	CcSEcCtD
Dicyclomine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000832	0.00118	CcSEcCtD
Dicyclomine—Pruritus—Etoposide—urinary bladder cancer	0.000827	0.00117	CcSEcCtD
Dicyclomine—Nausea—Gemcitabine—urinary bladder cancer	0.000813	0.00115	CcSEcCtD
Dicyclomine—Vomiting—Cisplatin—urinary bladder cancer	0.000812	0.00115	CcSEcCtD
Dicyclomine—Vision blurred—Methotrexate—urinary bladder cancer	0.000809	0.00115	CcSEcCtD
Dicyclomine—Mental disorder—Epirubicin—urinary bladder cancer	0.000808	0.00115	CcSEcCtD
Dicyclomine—Rash—Cisplatin—urinary bladder cancer	0.000805	0.00114	CcSEcCtD
Dicyclomine—Dermatitis—Cisplatin—urinary bladder cancer	0.000804	0.00114	CcSEcCtD
Dicyclomine—Erythema—Epirubicin—urinary bladder cancer	0.000803	0.00114	CcSEcCtD
Dicyclomine—Nausea—Fluorouracil—urinary bladder cancer	0.0008	0.00113	CcSEcCtD
Dicyclomine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000798	0.00113	CcSEcCtD
Dicyclomine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000796	0.00113	CcSEcCtD
Dicyclomine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000792	0.00112	CcSEcCtD
Dicyclomine—Tension—Epirubicin—urinary bladder cancer	0.000788	0.00112	CcSEcCtD
Dicyclomine—Nervousness—Epirubicin—urinary bladder cancer	0.00078	0.00111	CcSEcCtD
Dicyclomine—Malaise—Methotrexate—urinary bladder cancer	0.000774	0.0011	CcSEcCtD
Dicyclomine—Dizziness—Etoposide—urinary bladder cancer	0.000773	0.0011	CcSEcCtD
Dicyclomine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000771	0.00109	CcSEcCtD
Dicyclomine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000769	0.00109	CcSEcCtD
Dicyclomine—Nausea—Cisplatin—urinary bladder cancer	0.000758	0.00108	CcSEcCtD
Dicyclomine—Vision blurred—Epirubicin—urinary bladder cancer	0.000757	0.00107	CcSEcCtD
Dicyclomine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000748	0.00106	CcSEcCtD
Dicyclomine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000745	0.00106	CcSEcCtD
Dicyclomine—Vomiting—Etoposide—urinary bladder cancer	0.000744	0.00106	CcSEcCtD
Dicyclomine—Erythema—Doxorubicin—urinary bladder cancer	0.000743	0.00105	CcSEcCtD
Dicyclomine—Agitation—Epirubicin—urinary bladder cancer	0.000738	0.00105	CcSEcCtD
Dicyclomine—Rash—Etoposide—urinary bladder cancer	0.000737	0.00105	CcSEcCtD
Dicyclomine—Dermatitis—Etoposide—urinary bladder cancer	0.000737	0.00105	CcSEcCtD
Dicyclomine—Headache—Etoposide—urinary bladder cancer	0.000733	0.00104	CcSEcCtD
Dicyclomine—Tension—Doxorubicin—urinary bladder cancer	0.000729	0.00103	CcSEcCtD
Dicyclomine—Malaise—Epirubicin—urinary bladder cancer	0.000724	0.00103	CcSEcCtD
Dicyclomine—Discomfort—Methotrexate—urinary bladder cancer	0.000722	0.00102	CcSEcCtD
Dicyclomine—Nervousness—Doxorubicin—urinary bladder cancer	0.000722	0.00102	CcSEcCtD
Dicyclomine—Syncope—Epirubicin—urinary bladder cancer	0.00072	0.00102	CcSEcCtD
Dicyclomine—Palpitations—Epirubicin—urinary bladder cancer	0.00071	0.00101	CcSEcCtD
Dicyclomine—Confusional state—Methotrexate—urinary bladder cancer	0.000706	0.001	CcSEcCtD
Dicyclomine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000706	0.001	CcSEcCtD
Dicyclomine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.0007	0.000994	CcSEcCtD
Dicyclomine—Vision blurred—Doxorubicin—urinary bladder cancer	0.0007	0.000994	CcSEcCtD
Dicyclomine—Nausea—Etoposide—urinary bladder cancer	0.000695	0.000986	CcSEcCtD
Dicyclomine—Hypertension—Epirubicin—urinary bladder cancer	0.000693	0.000984	CcSEcCtD
Dicyclomine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00069	0.000979	CcSEcCtD
Dicyclomine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000687	0.000975	CcSEcCtD
Dicyclomine—Agitation—Doxorubicin—urinary bladder cancer	0.000683	0.000969	CcSEcCtD
Dicyclomine—Discomfort—Epirubicin—urinary bladder cancer	0.000676	0.000959	CcSEcCtD
Dicyclomine—Malaise—Doxorubicin—urinary bladder cancer	0.00067	0.000951	CcSEcCtD
Dicyclomine—Dry mouth—Epirubicin—urinary bladder cancer	0.000669	0.000949	CcSEcCtD
Dicyclomine—Anorexia—Methotrexate—urinary bladder cancer	0.000668	0.000947	CcSEcCtD
Dicyclomine—Syncope—Doxorubicin—urinary bladder cancer	0.000666	0.000946	CcSEcCtD
Dicyclomine—Confusional state—Epirubicin—urinary bladder cancer	0.000661	0.000938	CcSEcCtD
Dicyclomine—Palpitations—Doxorubicin—urinary bladder cancer	0.000657	0.000932	CcSEcCtD
Dicyclomine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000656	0.00093	CcSEcCtD
Dicyclomine—Oedema—Epirubicin—urinary bladder cancer	0.000656	0.00093	CcSEcCtD
Dicyclomine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000653	0.000927	CcSEcCtD
Dicyclomine—Shock—Epirubicin—urinary bladder cancer	0.000645	0.000915	CcSEcCtD
Dicyclomine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000643	0.000912	CcSEcCtD
Dicyclomine—Hypertension—Doxorubicin—urinary bladder cancer	0.000642	0.000911	CcSEcCtD
Dicyclomine—Tachycardia—Epirubicin—urinary bladder cancer	0.00064	0.000908	CcSEcCtD
Dicyclomine—Insomnia—Methotrexate—urinary bladder cancer	0.000634	0.000899	CcSEcCtD
Dicyclomine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000629	0.000893	CcSEcCtD
Dicyclomine—Discomfort—Doxorubicin—urinary bladder cancer	0.000625	0.000887	CcSEcCtD
Dicyclomine—Anorexia—Epirubicin—urinary bladder cancer	0.000625	0.000887	CcSEcCtD
Dicyclomine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000625	0.000886	CcSEcCtD
Dicyclomine—Somnolence—Methotrexate—urinary bladder cancer	0.000623	0.000884	CcSEcCtD
Dicyclomine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000619	0.000878	CcSEcCtD
Dicyclomine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000617	0.000875	CcSEcCtD
Dicyclomine—Confusional state—Doxorubicin—urinary bladder cancer	0.000612	0.000868	CcSEcCtD
Dicyclomine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000609	0.000864	CcSEcCtD
Dicyclomine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000607	0.000861	CcSEcCtD
Dicyclomine—Oedema—Doxorubicin—urinary bladder cancer	0.000607	0.000861	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000605	0.000858	CcSEcCtD
Dicyclomine—Fatigue—Methotrexate—urinary bladder cancer	0.000604	0.000857	CcSEcCtD
Dicyclomine—Pain—Methotrexate—urinary bladder cancer	0.000599	0.00085	CcSEcCtD
Dicyclomine—Shock—Doxorubicin—urinary bladder cancer	0.000597	0.000847	CcSEcCtD
Dicyclomine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000595	0.000844	CcSEcCtD
Dicyclomine—Insomnia—Epirubicin—urinary bladder cancer	0.000593	0.000841	CcSEcCtD
Dicyclomine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000592	0.00084	CcSEcCtD
Dicyclomine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000589	0.000835	CcSEcCtD
Dicyclomine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000584	0.000829	CcSEcCtD
Dicyclomine—Somnolence—Epirubicin—urinary bladder cancer	0.000583	0.000827	CcSEcCtD
Dicyclomine—Anorexia—Doxorubicin—urinary bladder cancer	0.000578	0.00082	CcSEcCtD
Dicyclomine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000577	0.000819	CcSEcCtD
Dicyclomine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000577	0.000819	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000573	0.000813	CcSEcCtD
Dicyclomine—Decreased appetite—Epirubicin—urinary bladder cancer	0.00057	0.000809	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000566	0.000803	CcSEcCtD
Dicyclomine—Fatigue—Epirubicin—urinary bladder cancer	0.000565	0.000802	CcSEcCtD
Dicyclomine—Constipation—Epirubicin—urinary bladder cancer	0.000561	0.000795	CcSEcCtD
Dicyclomine—Pain—Epirubicin—urinary bladder cancer	0.000561	0.000795	CcSEcCtD
Dicyclomine—Urticaria—Methotrexate—urinary bladder cancer	0.000556	0.00079	CcSEcCtD
Dicyclomine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000554	0.000786	CcSEcCtD
Dicyclomine—Insomnia—Doxorubicin—urinary bladder cancer	0.000549	0.000778	CcSEcCtD
Dicyclomine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000545	0.000773	CcSEcCtD
Dicyclomine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000541	0.000767	CcSEcCtD
Dicyclomine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00054	0.000767	CcSEcCtD
Dicyclomine—Somnolence—Doxorubicin—urinary bladder cancer	0.000539	0.000765	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000536	0.000761	CcSEcCtD
Dicyclomine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000534	0.000758	CcSEcCtD
Dicyclomine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000527	0.000748	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000524	0.000743	CcSEcCtD
Dicyclomine—Fatigue—Doxorubicin—urinary bladder cancer	0.000523	0.000742	CcSEcCtD
Dicyclomine—Urticaria—Epirubicin—urinary bladder cancer	0.000521	0.000739	CcSEcCtD
Dicyclomine—Constipation—Doxorubicin—urinary bladder cancer	0.000519	0.000736	CcSEcCtD
Dicyclomine—Pain—Doxorubicin—urinary bladder cancer	0.000519	0.000736	CcSEcCtD
Dicyclomine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000518	0.000735	CcSEcCtD
Dicyclomine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000516	0.000732	CcSEcCtD
Dicyclomine—Asthenia—Methotrexate—urinary bladder cancer	0.000503	0.000713	CcSEcCtD
Dicyclomine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.0005	0.000709	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000496	0.000704	CcSEcCtD
Dicyclomine—Pruritus—Methotrexate—urinary bladder cancer	0.000496	0.000703	CcSEcCtD
Dicyclomine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000483	0.000685	CcSEcCtD
Dicyclomine—Urticaria—Doxorubicin—urinary bladder cancer	0.000482	0.000684	CcSEcCtD
Dicyclomine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000479	0.00068	CcSEcCtD
Dicyclomine—Asthenia—Epirubicin—urinary bladder cancer	0.00047	0.000667	CcSEcCtD
Dicyclomine—Pruritus—Epirubicin—urinary bladder cancer	0.000464	0.000658	CcSEcCtD
Dicyclomine—Dizziness—Methotrexate—urinary bladder cancer	0.000463	0.000657	CcSEcCtD
Dicyclomine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000447	0.000634	CcSEcCtD
Dicyclomine—Vomiting—Methotrexate—urinary bladder cancer	0.000445	0.000632	CcSEcCtD
Dicyclomine—Rash—Methotrexate—urinary bladder cancer	0.000442	0.000627	CcSEcCtD
Dicyclomine—Dermatitis—Methotrexate—urinary bladder cancer	0.000441	0.000626	CcSEcCtD
Dicyclomine—Headache—Methotrexate—urinary bladder cancer	0.000439	0.000623	CcSEcCtD
Dicyclomine—Asthenia—Doxorubicin—urinary bladder cancer	0.000435	0.000618	CcSEcCtD
Dicyclomine—Dizziness—Epirubicin—urinary bladder cancer	0.000433	0.000615	CcSEcCtD
Dicyclomine—Pruritus—Doxorubicin—urinary bladder cancer	0.000429	0.000609	CcSEcCtD
Dicyclomine—Vomiting—Epirubicin—urinary bladder cancer	0.000417	0.000591	CcSEcCtD
Dicyclomine—Nausea—Methotrexate—urinary bladder cancer	0.000416	0.00059	CcSEcCtD
Dicyclomine—Rash—Epirubicin—urinary bladder cancer	0.000413	0.000587	CcSEcCtD
Dicyclomine—Dermatitis—Epirubicin—urinary bladder cancer	0.000413	0.000586	CcSEcCtD
Dicyclomine—Headache—Epirubicin—urinary bladder cancer	0.000411	0.000583	CcSEcCtD
Dicyclomine—Dizziness—Doxorubicin—urinary bladder cancer	0.000401	0.000569	CcSEcCtD
Dicyclomine—Nausea—Epirubicin—urinary bladder cancer	0.000389	0.000553	CcSEcCtD
Dicyclomine—Vomiting—Doxorubicin—urinary bladder cancer	0.000386	0.000547	CcSEcCtD
Dicyclomine—Rash—Doxorubicin—urinary bladder cancer	0.000382	0.000543	CcSEcCtD
Dicyclomine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000382	0.000542	CcSEcCtD
Dicyclomine—Headache—Doxorubicin—urinary bladder cancer	0.00038	0.000539	CcSEcCtD
Dicyclomine—Nausea—Doxorubicin—urinary bladder cancer	0.00036	0.000511	CcSEcCtD
